Maria Arantxa Horga

Insider Reports History

Location
Boston, MA
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Maria Arantxa Horga
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Maria Arantxa Horga:

Company Role Class Num Shares Value Price $ Report Date Ownership
Atea Pharmaceuticals, Inc. Chief Medical Officer Common Stock 96,086 $407,404 $4.24 31 Jan 2026 Direct
Atea Pharmaceuticals, Inc. Chief Medical Officer Restricted Stock Units 0 $29,835 $3.06 31 Jan 2026 Direct
Atea Pharmaceuticals, Inc. Chief Medical Officer Stock Option (Right to Buy) 173,500 31 Jan 2026 Direct

Insider Reports Filed by Maria Arantxa Horga

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2026 5 -$68,150 4 Chief Medical Officer 03 Feb 2026, 19:53
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2025 6 -$49,177 4 Chief Medical Officer 04 Feb 2025, 18:00
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2024 4 -$60,963 4 Chief Medical Officer 02 Feb 2024, 21:29
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2023 2 $0 4 Chief Medical Officer 02 Feb 2023, 17:35
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2022 1 $0 4 Chief Medical Officer 02 Feb 2022, 16:15